PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35278900-0	2022	Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-kappaB-mediated signaling pathway.	tubeimoside I	0-13	O-6-methylguanine-DNA methyltransferase	Homo sapiens	95-99